Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bottomly

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|June 26, 2023
Immune cell proportions correlate with clinicogenomic features and <i>ex vivo</i> drug responses in acute myeloid leukemiaKyle A Romine, Daniel Bottomly, William Yashar, et al.
Haematologica|December 30, 2020
Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemiaAlisa Damnernsawad, Daniel Bottomly, Stephen E Kurtz, et al.
Bioinformatics (Oxford, England)|January 11, 2013
HitWalker: variant prioritization for personalized functional cancer genomicsDaniel Bottomly, Beth Wilmot, Jeffrey W Tyner, et al.
British Journal of Haematology|June 13, 2024
Upregulation of HOXA3 by isoform-specific Wilms tumour 1 drives chemotherapy resistance in acute myeloid leukaemiaBasil Allen, Lindsey Savoy, Peter Ryabinin, et al.
American Journal of Hematology|March 29, 2021
A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistanceSunil K Joshi, Setareh Sharzehi, Janét Pittsenbarger, et al.
Scientific Data|February 11, 2026
Biomedical Data Manifest: A lightweight data documentation mapping to increase transparency for AI/MLDaniel Bottomly, Christopher G Suciu, Benjamin Cordier, et al.
Blood Cancer Discovery|September 27, 2021
Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid LeukemiaKyle A Romine, Tamilla Nechiporuk, Daniel Bottomly, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|December 31, 2013
The genetics of gene expression in complex mouse crosses as a tool to study the molecular underpinnings of behavior traitsRobert Hitzemann, Daniel Bottomly, Ovidiu Iancu, et al.
Genome Medicine|November 30, 2013
Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicineDaniel Bottomly, Peter A Ryabinin, Jeffrey W Tyner, et al.
Plos One|May 25, 2013
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulationLina Gao, Jacob Schwartzman, Angela Gibbs, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|June 26, 2023
Immune cell proportions correlate with clinicogenomic features and <i>ex vivo</i> drug responses in acute myeloid leukemiaKyle A Romine, Daniel Bottomly, William Yashar, et al.
Haematologica|December 30, 2020
Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemiaAlisa Damnernsawad, Daniel Bottomly, Stephen E Kurtz, et al.
Bioinformatics (Oxford, England)|January 11, 2013
HitWalker: variant prioritization for personalized functional cancer genomicsDaniel Bottomly, Beth Wilmot, Jeffrey W Tyner, et al.
British Journal of Haematology|June 13, 2024
Upregulation of HOXA3 by isoform-specific Wilms tumour 1 drives chemotherapy resistance in acute myeloid leukaemiaBasil Allen, Lindsey Savoy, Peter Ryabinin, et al.
American Journal of Hematology|March 29, 2021
A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistanceSunil K Joshi, Setareh Sharzehi, Janét Pittsenbarger, et al.
Scientific Data|February 11, 2026
Biomedical Data Manifest: A lightweight data documentation mapping to increase transparency for AI/MLDaniel Bottomly, Christopher G Suciu, Benjamin Cordier, et al.
Blood Cancer Discovery|September 27, 2021
Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid LeukemiaKyle A Romine, Tamilla Nechiporuk, Daniel Bottomly, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|December 31, 2013
The genetics of gene expression in complex mouse crosses as a tool to study the molecular underpinnings of behavior traitsRobert Hitzemann, Daniel Bottomly, Ovidiu Iancu, et al.
Genome Medicine|November 30, 2013
Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicineDaniel Bottomly, Peter A Ryabinin, Jeffrey W Tyner, et al.
Plos One|May 25, 2013
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulationLina Gao, Jacob Schwartzman, Angela Gibbs, et al.
Pageof 6